Overweight and obesity reduce life expectancy and increase the likelihood of weight-related comorbid conditions, such as hypertension, type 2 diabetes, hyperlipidemia, and cancer. Among adults globally, 59% have overweight or obesity. Among U.S. adults, more than 34% are estimated to have overweight and another 34% are estimated to have obesity, based on self-reported height and weight. The advent of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including multireceptor agonists, has renewed attention on drugs to treat obesity.
CME/MOC:
Up to 1
AMA PRA Category 1 Credits™ and MOC Points
Expires June 23, 2029
active
Cost:
Free to Members
Format:
Journal Articles
Product:
Annals Supplement
Annals of Internal Medicine occasionally publishes special supplements funded by non commercial entities and devoted to a specific clinical, educational, research, or policy relevant topic.
